| Identification | Back Directory | [Name]
BOC-PHE-D-LEU-PHE-D-LEU-PHE-OH | [CAS]
73572-58-4 | [Synonyms]
Boc-FLFLF, Boc-2
BOC-PHE-LEU-PHE-LEU-PHE
N-Boc-Phe-Leu-Phe-Leu-Phe
BOC-PHE-LEU-PHE-LEU-PHE-OH
N-T-BOC-PHE-LEU-PHE-LEU-PHE
BOC-PHE-D-LEU-PHE-D-LEU-PHE
BOC-PHE-D-LEU-PHE-D-LEU-PHE-OH
n-t-boc-phe-leu-phe-leu-phe,-20to0
N-T-BOC-PHE-LEU-PHE-LEU-PHE MINIMUM 90% (HPLC)
N(tert-BOC)-(phenylalanine-leucine)2-phenylalanine
L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl- | [Molecular Formula]
C44H59N5O8 | [MDL Number]
MFCD00076349 | [MOL File]
73572-58-4.mol | [Molecular Weight]
785.97 |
| Chemical Properties | Back Directory | [Boiling point ]
1043.2±65.0 °C(Predicted) | [density ]
1.167±0.06 g/cm3(Predicted) | [solubility ]
Chloroform: Slightly soluble: 0.1-1 mg/ml
Methanol: Slightly soluble: 0.1-1 mg/ml | [form ]
Solid | [pka]
3.51±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
Boc-Phe-Leu-Phe-Leu-Phe, a chemotactic peptide antagonist, abolishes the FMLP-induced release of peptide
leukotrienes[1]. | [References]
[1] A M Lefer, et al. Modulation of receptor mediated leukotriene release in the perfused heart. Gen Pharmacol. 1986;17(4):437-40. DOI:10.1016/0306-3623(86)90187-4 |
|
| Company Name: |
Ontores Biotech
|
| Telephone: |
0571-88760729 18072970094 |
| Website: |
www.ontoresinc.cn |
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|